← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Paclitaxel currently has availability issues reported in 3 European registers: France, Italy, Sweden.
Shortage ATC — · also listed as: paclitaxel · paklitaxel · data refreshed 5 September 2026
As of 5 September 2026, 3 of the 9 tracked registers list current availability issues for Paclitaxel, covering 12 affected product presentations. The longest-running open report was filed in Italy on 2022-05-30 and has now been open for about 52 months. Where agencies state a cause, manufacturing problems lead with 4 of the 9 stated-cause reports, followed by unexpectedly high demand with 3. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-09-30. Momentum is current, not historical: 4 of the open reports were filed within the last 90 days. Registers in Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇪🇺 EU-wide (EMA) | Resolved Abraxane (paclitaxel) + 1 more productsPazenir (paclitaxel) | 2023-01-26 | — | Breast Neoplasms;Pancreatic Neoplasms;Carcinoma, Non-Small-Cell Lung Alternatives: EMA lists available alternatives — see the EMA record. | register ↗ |
| 🇫🇷 France | Limited availability Paclitaxel AHCL 6 mg/ml, solution à diluer pour perfusion - flacons de 50 ml et 100 ml | — | — | Oncologie/Radiothérapie | register ↗ |
| 🇮🇹 Italy | Shortage NAVERUCLIF + 7 more productsPACLITAXEL ACCORD HEALTHCARE ITALIA PACLITAXEL ACCORD HEALTHCARE ITALIA PACLITAXEL ACCORD HEALTHCARE ITALIA PACLITAXEL ACCORD HEALTHCARE ITALIA PACLITAXEL ACCORD HEALTHCARE ITALIA PACLITAXEL AUROBINDO PACLITAXEL SANDOZ | 2022-05-30 | — | Elevata richiesta Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
| 🇸🇪 Sweden | Shortage NAVERUCLIF 5 mg/ml Pulver till infusionsvätska, dispersion + 2 more productsPacligen 6 mg/ml Koncentrat till infusionsvätska, lösning Paclitaxel Fresenius Kabi 6 mg/ml Koncentrat till infusionsvätska, lösning | 2023-07-16 | 2026-12-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Paclitaxel in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | PACLITAXEL SANDOZ | Shortage | 2026-12-21 | — | Cessata commercializzazione definitiva |
| 🇮🇹 IT | PACLITAXEL ACCORD HEALTHCARE ITALIA | Shortage | 2026-09-30 | — | Problemi produttivi |
| 🇮🇹 IT | PACLITAXEL ACCORD HEALTHCARE ITALIA | Shortage | 2026-07-10 | — | Elevata richiesta |
| 🇮🇹 IT | NAVERUCLIF | Shortage | 2026-07-01 | — | Elevata richiesta |
| 🇮🇹 IT | PACLITAXEL AUROBINDO | Shortage | 2026-06-01 | — | Problemi produttivi |
| 🇮🇹 IT | PACLITAXEL ACCORD HEALTHCARE ITALIA | Shortage | 2026-05-22 | — | Elevata richiesta |
| 🇸🇪 SE | NAVERUCLIF 5 mg/ml Pulver till infusionsvätska, dispersion | Shortage | 2026-03-15 | 2026-09-30 | |
| 🇸🇪 SE | Paclitaxel Fresenius Kabi 6 mg/ml Koncentrat till infusionsvätska, lös | Shortage | 2026-02-01 | 2026-12-31 | |
| 🇸🇪 SE | Pacligen 6 mg/ml Koncentrat till infusionsvätska, lösning | Shortage | 2023-07-16 | 2026-12-31 | |
| 🇪🇺 EU | Abraxane (paclitaxel) | Resolved | 2023-05-11 | — | Breast Neoplasms;Pancreatic Neoplasms;Carcinoma, Non-Small-C |
| 🇪🇺 EU | Pazenir (paclitaxel) | Resolved | 2023-01-26 | — | Breast Neoplasms |
| 🇮🇹 IT | PACLITAXEL ACCORD HEALTHCARE ITALIA | Shortage | 2023-01-20 | — | Problemi produttivi |
| 🇮🇹 IT | PACLITAXEL ACCORD HEALTHCARE ITALIA | Shortage | 2022-05-30 | — | Problemi produttivi |
| 🇫🇷 FR | Paclitaxel AHCL 6 mg/ml, solution à diluer pour perfusion - flacons de | Limited availability | — | — | Oncologie/Radiothérapie |
Yes. As of 5 September 2026, availability issues are reported in: France, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-30 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
11 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Paclitaxel: EMA shortages catalogue (EU), ANSM (France), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Paclitaxel — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/paclitaxel/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Paclitaxel availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/paclitaxel/">Paclitaxel shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>